Frank Strutz

Title: Frank Strutz: Innovator in Renal Disease Diagnostics

Introduction

Frank Strutz is a notable inventor based in Mainz, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the area of renal disease. His innovative work has led to the development of a patented method that enhances the diagnosis and prediction of renal diseases in patients.

Latest Patents

Frank Strutz holds a patent for his invention titled "Biomarkers for renal disease." This invention provides methods and kits for diagnosing renal disease in patients or predicting the risk of developing such diseases. The patent outlines a method that involves determining the level of a specific ubiquitin fragment, with a mass-to-charge ratio (m/z) of 6188, in a patient-derived sample. A reduced level of this ubiquitin fragment compared to a control is indicative of renal disease, thus offering a valuable tool for early diagnosis.

Career Highlights

Strutz is affiliated with the Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin. His work at this esteemed institution has allowed him to collaborate with other experts in the field, further advancing research in renal diagnostics. His dedication to innovation in medical technology has positioned him as a key figure in this area.

Collaborations

Some of Frank Strutz's notable coworkers include Hassan Dihazi and Gerhard A. Müller. Their collaborative efforts contribute to the ongoing research and development of diagnostic methods that can significantly impact patient care.

Conclusion

Frank Strutz's contributions to renal disease diagnostics through his patented invention exemplify the importance of innovation in medicine. His work not only enhances diagnostic accuracy but also holds the potential to improve patient outcomes significantly.